Worldwide Recall of EpiPen, Used for Emergent Allergic Reactions, Now Includes America

The U.S. has finally joined other nations in a recall of EpiPen auto-injectors for emergency allergic reactions, as the result of the injector mechanism defect. When properly functioning, the EpiPen delivers a potentially life-saving dose of adrenalin, via a large needle.

Mylan, the company that markets the device, announced earlier this month that it was recalling about 80,000 EpiPens in Australia, Europe, Japan, and New Zealand. It reported two events when the injector failed to deliver its dose.

Proper administration involves pressing the EpiPen into a victim’s thigh, which shoots a needle through the skin and injects epinephrine into muscle.

The company announced today that it is expanding the recall not only to the United States, but also other markets in North America and South America.

In the United States, the recall applies to 13 lots of both EpiPen and EpiPen Jr. auto-injectors, distributed between December 2015-July 2016. Patients are being told theycan receive another EpiPen or an authorized generic version at their pharmacy, Mylan said. In the meantime, they are advised to continue carrying their current EpiPen until they get a replacement.

Here are the ones under recall, so check your pens carefully:

Product/Dosage

NDC Number

Lot Number

Expiration Date

EpiPen Jr Auto-Injector, 0.15 mg

49502-501-02

5GN767

April 2017

EpiPen Jr Auto-Injector, 0.15 mg

49502-501-02

5GN773

April 2017

EpiPen Auto-Injector, 0.3 mg

49502-500-02

5GM631

April 2017

EpiPen Auto-Injector, 0.3 mg

49502-500-02

5GM640

May 2017

EpiPen Jr Auto-Injector, 0.15 mg

49502-501-02

6GN215

September 2017

EpiPen Auto-Injector, 0.3 mg

49502-500-02

6GM082

September 2017

EpiPen Auto-Injector, 0.3 mg

49502-500-02

6GM072

September 2017

EpiPen Auto-Injector, 0.3 mg

49502-500-02

6GM081

September 2017

EpiPen Auto-Injector, 0.3 mg

49502-500-02

6GM088

October 2017

EpiPen Auto-Injector, 0.3 mg

49502-500-02

6GM199

October 2017

EpiPen Auto-Injector, 0.3 mg

49502-500-02

6GM091

October 2017

EpiPen Auto-Injector, 0.3 mg

49502-500-02

6GM198

October 2017

EpiPen Auto-Injector, 0.3 mg

49502-500-02

6GM087

October 2017

EpiPens are made by Meridian Medical Technologies, a subsidiary of Pfizer.

 

Heather Bresch Mylan CEO

Who cares if families can’t afford them? I make $400,000 a week!

You may recall the ugly pharmaceutical revelation of last year, when Mylan CEO Heather Bresch’s salary jumped 670% – from $2,453,456 to $18,931,068, during the same period the company raised EpiPen prices, from $56 to $317 – a 460% increase.

For questions, EpiPen users can reach Mylan at 800 796 9526 or email customer service at customer.service@mylan.com.

To report problems with EpiPen auto-injectors, contact MedWatch, the FDA’s safety information and adverse event reporting program, by telephone at 1-800-FDA-1088; by fax at 1-800-FDA-0178; online at https://www.accessdata.fda.gov/scripts/medwatch/medwatch-online.htm;

Here’s some background on the EpiPen drug pushers: